Hong Kong Hung To Group

Hung To Group (Holdings) Limited is a Hong Kong-based investment holding company with a primary focus on the life sciences and biotechnology sectors. The group is most recognized as the founding entity and a major shareholder of Aptorum Group Limited, a clinical-stage biopharmaceutical company listed on the Nasdaq. Through its strategic management, Hung To Group facilitates the translation of early-stage medical research into clinical-stage therapeutic and diagnostic programs. Its portfolio primarily addresses unmet medical needs in infectious diseases, oncology, and rare diseases. The company operates by identifying promising technologies from academic institutions and providing the necessary capital and expertise for their development. Hung To Group plays a pivotal role in the Hong Kong biotech ecosystem through its leadership and investment activities.